Featured healthcare product

AJISTA LITE

Escitalopram Oxalate 10 mg & Clonazepam 0.25 mg tablets

AJISTA LITE combines Escitalopram Oxalate with Clonazepam in a dual-action formulation intended for patients requiring rapid anxiety relief alongside antidepressant support.

The brochure highlights this combination as a first-line approach for depressive disorders, offering more rapid control of anxiety, reduced agitation, improved adherence to antidepressant therapy, and better management of episodic or situational anxiety.

Product highlights

  • Unique first-line therapy for depressive disorders
  • More efficacious than all other SSRIs
  • Dual mode of action for anxiety and depression support
  • Does not cause sedation and avoids anti-cholinergic or cardiac side effects

Clinical focus

AJISTA LITE is designed for patients needing combined support for depressive symptoms and anxiety, with a formulation that aims to improve symptom control while supporting adherence to therapy.

Key product details

Active ingredients: Escitalopram Oxalate + Clonazepam
Strengths: 10 mg / 0.25 mg tablets
Use: Depression, anxiety, agitation, and situational anxiety under medical supervision.